The company said Stryker's 2023 net sales rose 11.1% as reported, with net earnings of $3,165 and net earnings per diluted share of $8.25. Adjusted net earnings were $4,066 and adjusted net earnings per diluted share were $10.60, up 13.5%.

1. 01

   The company said Stryker's 2023 net sales rose 11.1% as reported, with net earnings of $3,165 and net earnings per diluted share of $8.25. Adjusted net earnings were $4,066 and adjusted net earnings per diluted share were $10.60, up 13.5%.

2. 02

   The company said its gross profit as a percentage of net sales rose to 62.8% in 2023 from 63.7% in 2022. Operating income was $3,888 in 2023, or 19.0% of net sales, and $2,841 in 2022 (15.4%).

3. 03

   The company said cash provided by operating activities in 2023 was $3,711, compared with $2,624 in 2022 and $3,263 in 2021. It cited higher net earnings and increased collections on accounts receivable as factors in the increase over 2022.

4. 04

   The company said it spent $390 on acquisitions and $1,139 on dividends in 2023. It also repaid the remaining balance of the $1.5 billion term loan, $850, and repaid and issued senior unsecured notes.

Key figures

Fiscal year ended December 31, 2023

Revenue

$20.5B

Operating income

$3.9B

Net income

$3.2B

EPS

$8.25

Gross profit

$13.1B

Operating cash flow

$3.7B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.